Many women with cancer missing fertility risk info, services

Share this article:

Few women of childbearing age who are diagnosed with cancer are taking steps to preserve their fertility during treatment, and sociodemographic health disparities likely affect access to fertility preservation services, according to recent study findings.

A total of 1,041 women who had been diagnosed with leukemia, Hodgkin disease, non-Hodgkin lymphoma, breast cancer, or GI cancer from 1993 to 2007, when the patients were 18 to 40 years old, responded to a retrospective survey on demographic information and reproductive health history. Of the respondents, 918 reported undergoing treatment that had the potential to affect fertility: chemotherapy, pelvic radiation, pelvic surgery, or bone marrow transplant.

Overall, only 4% of women pursued fertility preservation, but those rates had increased over time: Whereas just 1% of these patients pursued fertility preservation in 1993, 6% did so in 2005 and 10% did so in 2007. Nearly two-thirds (61%) of the women stated that their oncology team had counseled them on the fertility risks of cancer treatment.

Multivariate analyses of the responses revealed that the women who were childless, younger, Caucasian, heterosexual, and college graduates were more likely than other participants to receive counseling regarding the fertility risks posed by cancer treatment or to preserve fertility before cancer treatment.

“Although awareness of fertility preservation has improved in the past decade, an unmet need remains for reproductive health counseling and fertility preservation in reproductive-age women diagnosed with cancer,” concluded study authors Mitchell P. Rosen, MD, of the University of California, San Francisco, and colleagues, in their report for Cancer.


Share this article:
You must be a registered member of ONA to post a comment.

Next Article in Web Exclusives

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Hope for preserving fertility in young boys with cancer

Scientists have moved a step closer to being able to preserve fertility in young boys who undergo chemotherapy and radiation treatments for cancer.

Certain genetic variants increase recurrence risk for bladder cancer

Inheriting certain DNA sequences can affect the prognosis of bladder cancer patients, according to a new study.

Adult cancer drug offers hope against aggressive pediatric brain tumor

The quest to improve survival of children with a high-risk brain tumor has led investigators to two drugs already used to treat adults with breast, pancreatic, lung, and other cancers.